Hematocrit Changes as Parameters for Giving Mannitol in Severe Head Injury
Sriwijaya Journal of Surgery · 2018
DOI: 10.37275/sjs.v1i2.8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sriwijaya Journal of Surgery, 2018. Verfasst von Donny Valensius Susanto und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Introduction
Incidence of head injuries is also quite high in Indonesia, around 1.4 million cases per year with a mortality rate of 15-20% in the population aged 5 to 35 years. Head injuries are commonly divided into two separate time periods namely primary and secondary brain injuries. Primary brain injury is physical damage to the parenchyma (tissue and blood vessels) that occurs during a traumatic event, thus causing compression of the surrounding brain tissue. Secondary brain injury is a continuation of the results of primary brain injury with the main complications of brain injury in the following hours and days. This study was aimed to asses the benefits of administration of mannitol in cases of severe head injury in South Sumatra, Indonesia.
Methods
This research was a clinical trial without comparison by looking at hematocrit levels in patients with severe head injuries with intracranial hypertension before and after given mannitol therapy. Data analysis was performed with IBM SPSS Version 23. Data was presented in the form of narrative tables. Then the paired T test was performed. P value
Zitieren
APA
Susanto, D. V., & Permono, T. (2018). Hematocrit Changes as Parameters for Giving Mannitol in Severe Head Injury. Sriwijaya Journal of Surgery. https://doi.org/10.37275/sjs.v1i2.8
Vancouver
Susanto DV, Permono T. Hematocrit Changes as Parameters for Giving Mannitol in Severe Head Injury. Sriwijaya Journal of Surgery. 2018. doi:10.37275/sjs.v1i2.8
BibTeX
@article{Susanto2018,
author = {Susanto, Donny Valensius and Permono, Trijoso},
title = {Hematocrit Changes as Parameters for Giving Mannitol in Severe Head Injury},
journal = {Sriwijaya Journal of Surgery},
year = {2018},
doi = {10.37275/sjs.v1i2.8}
}
EUVIMED